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1. Introduction 
The presence of harmful pathogenic microorganisms is a growing problem in healthcare, 
food, feed and the environment. In addition, the increasing appearance of antibiotic resistant 
microorganisms adversely affects this situation. In the current standard detection methods 
time-consuming and expensive enrichment protocols are being used. Generally, these 
methods need to be performed in highly equipped laboratories by trained personnel. Often 
the time needed to confirm the presence of a particular pathogen using standard methods 
averages 2 to 7 days, which is too long to timely take actions. In human health for example 
this lack of speed can result in lost working hours, hospitalization or even death. The recent 
outbreak of food-borne Escherichia coli in Germany and other European countries (May 2011) 
has shown the dramatic consequences of pathogen contaminated food (Askar et al. 2011; 
Frank et al. 2011). Apart from E. coli there are several other pathogenic microorganisms that 
have to be monitored intensively in the food chain. Amongst those are Bacillus cereus, Listeria 
monocytogenes and Salmonella typhimurium. As different strains of these species may have 
various degrees of pathogenicity it is very informative to be able to discriminate between 
harmless and harmful strains. In food production good manufacturing programs were set 
up to ensure food safety. To comply with these safety rules it would be advantageous to 
have a versatile, fast, low-cost and on-site assay format available for (on-line) monitoring of 
food-borne pathogens with a suitable number of target organisms. In the majority of 
diagnostic questions this number is 5 to maximally 10. 
Many efforts have been made to speed up the detection of harmful microorganisms, the 
focus of these developments being on faster, more sensitive and more convenient methods 
(Mandal et al. 2011). Especially when handling large amounts of samples it is a great asset if 
a detection method allows for medium- to high-throughput screening. In these cases it is 
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also valuable if the steps from sample processing to read-out of the results have been 
maximally automated. 
In drug discovery and life sciences research both DNA and, increasingly, protein 
microarrays are crucial tools (Timlin 2006), whereas the application of microarrays as 
diagnostics is very promising (Venkatasubbarao 2004). Pathogen detection in food by DNA 
microarrays has been reported by various groups (D'Agostino et al. 2004; Glynn et al. 2006; 
Kostrzynska & Bachand 2006; Volokhov et al. 2002). However, despite its high potential the 
microarray platform is still not an emerging tool in the regular diagnostic field, especially in 
the case of protein microarrays (Dieterle & Marrer 2008). Several reasons may be responsible 
for this limited presence of protein microarrays such as the lack of sufficient biological 
recognition elements (e.g., antibodies) and/or their sensitivity and specificity and the 
inferior conformational stability that some proteins may have. Many problems have still to 
be overcome for validated in vitro diagnostics using protein microarrays (Hartmann et al. 
2009). 
To increase the applicability and to reduce the costs of protein microarrays we investigated 
the use of carbon nanoparticles as signal labels and a conventional flatbed scanner to 
digitize the image. A nucleic acid detection format was used employing double-tagged 
amplicons that can be sandwiched between array-immobilised anti-tag antibodies and 
neutravidin coated carbon nanoparticles. The image was processed using image analysis 
software to produce the pixel grey volume of the spots generated by the label. As an 
alternative label to gold and latex, carbon nanoparticles have been used to develop lateral 
flow immunoassays (LFIA) for over 15 years (Aldus et al. 2003; Capps et al. 2004; Kalogianni 
et al. 2011; Koets et al. 2006; Koets et al. 2011; Lonnberg et al. 2008; Noguera et al. 2011; 
Posthuma-Trumpie et al. 2008; van Amerongen et al. 1993; van Amerongen & Koets 2005; 
van Dam et al. 2004). The possibility to use the pixel grey volume of the carbon particles in 
data processing following digitization by a CCD camera and image analysis was already 
shown in 1994 in a comparison between a simple one-step lateral flow immunoassay and a 
radioimmunoassay specific for the human choriogonadotropin hormone (van Amerongen et 
al. 1994). Excellent agreement was achieved among these two techniques with a correlation 
coefficient of 0.999. The use of a conventional flatbed scanner to digitize carbon lines was 
described (Lonnberg & Carlsson 2001), which by that time was 300 times more sensitive 
than the CCD camera used in 1994 (van Amerongen et al. 1994). In a recent PubMed 
literature survey conducted by FIND Diagnostics and published in Clinical Chemistry on 
the sensitivity of lateral flow immunoassays (Gordon & Michel 2008) the sensitivity of the 
carbon label was calculated to be in the low picomolar range for LFIAs specific for a 
Schistosomiasis carbohydrate antigen and fungal alpha-amylase, respectively, even when the 
assays were judged by visual inspection (Koets et al. 2006; van Dam et al. 2004). The position 
occupied by carbon nanoparticles in the sensitivity ranking list of nanoparticles (Gordon & 
Michel 2008) holds great promise for the application of these particles as signal labels in 
microarrays too. Recently, a review about the carbon label in diagnostics has been published 
(Posthuma-Trumpie et al. 2012). 
In this chapter we describe the multi-analyte detection of amplified DNA using an antibody 
microarray. The nucleic acid detection is based on the use of tagged primers in a PCR 
resulting in double-tagged amplicons that can be sandwiched between immobilised anti-tag 
antibodies and neutravidin. Reverse primers were tagged by using biotin and forward 
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primers by discriminating tags such as digoxigenin (DIG), dinitrophenol (DNP), fluorescein 
(FL), and Texas Red (TxR). In this one-step format, the labelled amplicons were mixed with 
the conjugate of neutravidin and carbon nanoparticles in incubation buffer, immediately 
applied and detected after one to several hours. Such mixed immuno-DNA formats have 
been used in lateral flow and microfluidic detection assays (Baeumner 2004; Blazkova et al. 
2009; Blazkova et al. 2011; Corstjens et al. 2001; Koets et al. 2009; Kozwich et al. 2000; Mens 
et al. 2008; Noguera et al. 2011; van Amerongen & Koets 2005; Wang et al. 2006). To get 
proof of concept for the use of carbon nanoparticles as signal labels in antibody microarrays 
we studied two applications in which the antigens consisted of double-tagged DNA 
amplicons: the detection of L. monocytogenes and the detection of three antibiotic resistance 
genes from Salmonella spp. (D'Agostino et al. 2004; van Hoek et al. 2005). 
2. Materials and methods 
2.1 Chemicals 
NeutrAvidin Biotin-Binding Protein (neutravidin) and biotin-labelled bovine serum 
albumin were from Pierce Biotechnology (Perbio Science Nederland BV, Etten-Leur, The 
Netherlands); anti-digoxigenin antibody (-DIG) and MgCl2 were from Roche (Almere, The 
Netherlands); anti-texas red antibody (ǂ-TxR) and goat anti-human immunoglobulin G (ǂ-
hIgG) were from Molecular Probes (Paisly, UK); anti-fluorescein antibody (ǂ-FL) was 
obtained from Biomeda (Foster City, California, USA) and anti-dinitrophenol antibody 
(ǂ-DNP) was from USBiological (Swampscott, USA). Human IgG, mouse IgG, Bovine serum 
albumin (BSA), essentially IgG free, and fluorescein isothiocyanate were from Sigma 
(Sigma-Aldrich Chemie B.V., Zwijndrecht, The Netherlands). Primers were from Eurogentec 
(Eurogentec Nederland bv, Maastricht, The Netherlands); dNTPs were from Pharmacia 
Biotech (GE Healthcare Europe GMBH, Branch office Benelux, Diegem, Belgium). Other 
chemicals were of the highest purity available and purchased from Merck (Amsterdam, The 
Netherlands). 
2.2 Polymerase Chain Reaction 
All PCRs were performed in the GeneAmp 9700 96 well thermal cycler (Applied Biosystems, 
Foster City, CA, USA). The resulting PCR products were analysed with an Agilent 2100 
Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA) using the DNA 1000 kit. 
Bacillus cereus: A set of primers was used to amplify part of the gyrB1 gene sequence. The 
reverse primer was 5’-tagged with DIG and the forward primer with biotin. Primer 
sequences are shown in Table 1. The reaction mixture consisted of 1 µL B. cereus genomic 
DNA, 25 µL redTaq mastermix (Sigma), 10 pmol Rprimer, 10 pmol Fprimer, in a final 
reaction volume of 50 µL. The amplification reaction consisted of an initial denaturation step 
of 5 min at 94 ºC, and 30 cycles of each 30 s 94 ºC, 30 s 55 ºC and 1 min 72 ºC, followed by the 
final polymerisation at 74 °C for 5 min. In Fig. 1 a scheme of the technique is depicted. 
Listeria spp.: A set of primers specific for L. monocytogenes was used to amplify a part 
(274 bp) of the prfA gene encoding the central virulence gene regulator as described 
(Blazkova et al. 2009). One of these primers was 5’-tagged with DIG and the other with 
biotin. To detect all Listeria species, a generic primer set for amplification of Listeria spp. has 
been selected (Herman et al. 1995), this primer set has been labelled with fluorescein/biotin. 
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Primer Sequences Tag Specificity Ref. 
gyrB Bc1 5’-ATTGGTGACACCGATCAAACA-3’ Biotin B. cereus (Chen & 
Tsen 2002) 
gyrB Bc2r 5’-TCATACGTATGGATGTTATTC-3’ DIG B. cereus (Chen & 
Tsen 2002) 
prfA LIP1 5’-GAT ACA GAA ACA TCG GTT GGC-3’ Biotin L. monocytogenes (D'Agostino 
et al. 2004) 
prfA LIP2 5’-GTG TAA TCT TGA TGC CAT CAG G-3’ DIG L. monocytogenes (D'Agostino 
et al. 2004) 
16S rRNA 
C 
5’-AGG TTG ACC CTA CCG ACTTC-3’ Biotin Listeria spp. (Herman et 
al. 1995) 
16S rRNA 
D 
5’-CAA GGA TAA GAG TAA CTG C-3’ FL Listeria spp. (Herman et 
al. 1995) 
tet(G)-F 5’-AAA GCC GGT TCG CAT CAA AC-3’ DNP tetracycline 
resistance gene 
Van Hoek, 
pers. comm. 
tet(G)-R 5’-GGA AGA TCG CAT GTG TTG CC-3’ Biotin tetracycline 
resistance gene 
Van Hoek, 
pers. comm. 
aadA2-F 5’-GCA GCG CAA TGA CAT TCT TG-3’ TxR streptomycin 
resistance gene 
(van Hoek 
et al. 2005) 
aadA2-R 5’-CAT CCT TCG GCG CGA TTT TG-3’ Biotin streptomycin 
resistance gene 
(van Hoek 
et al. 2005) 
blaPSE-1-F 5’-CGC TAT CTG AAA TGA ACC AG-3’ DIG ǃ-lactam 
resistance gene 
(van Hoek 
et al. 2005) 
blaPSE-1-R 5’-TTT CGC TCT GCC ATT GAA GC-3’ Biotin ǃ -lactam 
resistance gene 
(van Hoek 
et al. 2005) 
Table 1. Primer sequences used to amplify target microorganisms 
S. typhimurium antibiotic resistance genes: The three resistance gene specific forward primers 
were 5'-tagged with a distinguishing tag: tetracycline with a DNP-tag, streptomycin with a 
TxR-tag and ǃ-lactam with a DIG-tag. The reverse primers were labelled with a common 
biotin tag (Table 1). The amplification was performed using the Accu Prime PCR reaction kit 
(Invitrogen, Breda, The Netherlands). The reaction mixture consisted of 5 µL 10x Accu Prime 
PCR buffer II, 10 pmol primer for the single analyte assay, 20 pmol primers for the multiplexed 
assay, 2.5 U Accu Prime Taq polymerase, 40 ng genomic DNA in a final volume of 50 µL. 
Amplification was performed as follows: 30 s at 94 ºC, 30 cycles of 30 s at 94 ºC, 30 s at 55.8 ºC 
and 1 min at 68 ºC. After 30 cycles, the mixture was kept at 72 ºC for 7 min. 
 
Fig. 1. Scheme of the amplification technique incorporating tags during amplification and a 
photograph of a low-cost and fast thermocycler to perform the amplification. 
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Primer sequences are shown in Table 1. The reaction mixture consisted of 2.5 mM MgCl2, 
0.15 mM dNTP, 0.1 µM primers LIP1 and LIP2, 0.2 µM of primers C and D, 2 U FastStart Taq 
DNA Polymerase (Roche, Almere, The Netherlands), 2 µL genomic DNA in a final volume 
of 25 µL. The amplification program consisted of an initial denaturation step at 95 °C for 
4 min, 25 cycles each having a denaturation step at 94 °C for 30 s, annealing at 55 °C for 30 s 
and polymerisation at 74 °C for 1 min, followed by the final polymerisation at 74 °C for  
5 min.  
2.3 Preparation of carbon nanoparticles – NeutrAvidin conjugate 
Neutravidin was conjugated to colloidal nanoparticles as described in several patents by 
van Doorn et al. (van Doorn et al. 1987, 1996, 1997). Briefly, a colloidal carbon suspension 
(Spezial Schwartz 4, Evonik Degussa Industries AG, Essen Germany) was prepared as a 
stock at 1% (w/v) in demineralised water. The suspension was sonicated for 5-10 min on ice 
using a Branson model 250 sonifier (output control 3~27 W, 20 KHz). This carbon 
suspension was diluted five times with 5 mM borate buffer pH 8.8 to give a carbon 
concentration of 0.2% (w/v), and sonicated for a second time as above. Neutravidin 
dissolved in 5 mM borate buffer pH 8.8 was added to the diluted colloidal carbon 
suspension at a concentration of 350 μg of protein per mL of suspension. The pH was 
readjusted to pH 8.8 and the mixture was incubated overnight by end-over-end mixing at 
4 °C. Neutravidin-carbon conjugate was washed two times in a 5 mM borate buffer, pH 8.8, 
containing 1% (w/v) BSA, and re-suspended and stored in a 100 mM borate buffer, pH 8.8, 
containing 1% (w/v) BSA, 0.02% (w/v) NaN3 as a 0.2% (w/v) carbon suspension. 
2.4 Preparation of microarrays  
Antibodies and other proteins were spotted on microscope glass slides by means of a 
TopSpot device (BioFluidix GmbH, Freiburg, Germany) (de Heij et al. 2004), which is a non-
contact printing method. A 24-channel print head was employed for delivering ≈1 nL 
droplets onto a substrate from which immobilisation of anti-tag antibody and other proteins 
was allowed to take place (Fig. 2). This resulted in an array of 4×6 protein spots with a pitch 
of 500 µm. Spot diameters are variable and depend on the type of protein, type of substrate, 
and printing buffer composition and viscosity. In between printing runs the print head was 
cleaned by ultrasonic treatment for 10 minutes in a 0.12 M NaOH/1% (v/v) Triton X-100 
cleaning solution. 
  
Fig. 2. The Topspot/E (left) and the formation of droplets from the print head (right). 
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Three different, commercially obtained, types of glass substrates were used. Antibody arrays 
of ǂ-DIG, ǂ-FL, ǂ-TxR, and ǂ-DNP were prepared on these very types of substrate as follows:  
1. UltraStick slides (Ted Pella Inc., Redding, CA, USA): 3-aminopropyl-triethoxysilane 
(APTES)-modified glass consisting of a monolayer functionalized with primary amino 
groups useful for adsorption of proteins. Printing was performed using different 
concentrations of human IgG, anti-DIG antibody and FL-labelled mouse IgG in PBS. 
Immediately after arraying, the slides were placed in a humidity chamber and incubated 
at room temperature for 30 min in order to allow protein adsorption to proceed. Care was 
taken to prevent any drying of the spotted droplets. After incubation, the slides were 
flushed extensively with washing solution (10% (w/v) BSA in Phosphate Buffered Saline 
(PBS)) and arrays were kept covered with fresh washing solution for 10 minutes. Usage of 
this high protein containing washing solution is essential in order to prevent the smearing 
of the surplus IgG that had not adsorbed in the first step. Slides containing human IgG 
spots were incubated with FL-labelled anti-human IgG. Finally, the slides were rinsed 
quickly with PBS and MilliQ before being dried under a gentle stream of nitrogen gas. 
After completion of the procedure, the arrays containing the FL-labelled IgGs were 
observed by fluorescence microscopy employing an inverted Olympus IX51 microscope 
equipped with a mercury arc in combination with an Olympus U-MWB2 filter. Images 
were taken with a digital ColorViewII CCD camera (Soft Imaging Systems, Münster, 
Germany). 
2. SL HCX slides (XanTec bioanalytics GmbH, Düsseldorf, Germany): contain an attached 
layer of N-hydroxysuccinimide-activated carboxylated hydrogel (<5 µm thick), attached 
to borosilicate glass, that can be used for covalent coupling of proteins. Printing was 
done with different concentrations of anti-DIG and anti-FL antibody in PBS. Directly 
after printing the array was incubated for 4 h in a humidity chamber at room 
temperature. After immobilization, any residual activated groups on the slide surface 
were quenched by reaction for 10 min with ethanolamine (1 M, pH 8.0) at room 
temperature. After quenching, the slides were rinsed quickly with MilliQ and, finally, 
the slides were dried by applying a gentle stream of nitrogen gas. 
3. FAST™ 16 slides (Whatman Nederland BV, 's-Hertogenbosch, The Netherlands): on a 
standard microscope slide are positioned two rows of eight pads (5x5 mm) of an 11 µm 
thick microporous (0.2 µm pore size) nitrocellulose film for irreversible adsorption of 
proteins. Arrays of different concentrations and combinations of anti-DIG, anti-FL, anti-
TxR, and anti-DNP antibodies were spotted on FAST16 slides. Printing buffer was  
5 mM borate buffer, pH 8.8. Immediately after printing the slides were put in an 
incubator at 37 °C for 3 hours. No blocking step was used. 
2.5 Amplicon detection assay 
Incubations were performed in a dedicated slide holder with varying amounts (0.5-2 µL) 
(0.2% w/v) of colloidal carbon nanoparticles with immobilised neutravidin (Fig. 3a) and 
varying amounts (25, 50 or 75 µL) of incubation buffer (100 mM borate, 1% (w/v) BSA, 
0.05% (v/v) Tween20, 0.02% (w/v) NaN3, pH 8.8). Following the incubation, positive spots 
could be easily detected (Fig. 3b) when amplicons were sandwiched between anti-tag 
antibodies and (black) carbon-neutravidin particles as shown Fig. 3b,c. Control spots (no 
antibody printed) were used as negative controls. Arrays were recorded by conventional 
flatbed scanning using an Epson 3200 Photo scanner (Seiko Epson, Nagano, Japan). The 
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Pixel Grey Volume of positive spots were obtained using image analysis software (TotalLab, 
Nonlinear Dynamics, Newcastle upon Tyne, UK). Microsoft Excel and SigmaPlot 11 (Systat 
Software, Inc., San Jose, CA, USA) were used for subsequent data analysis and visualisation 
of the results. 
 
Fig. 3. Overview of antibody microarray tools and the test layout: a) holder for 4 slides with 
incubation chamber set-up (16 per slide); b) example of six membranes with 24 spot arrays; 
c) drawing of part of the nitrocellulose membrane with anti-tag antibody, 2-tagged amplicon 
and neutravidin-coated carbon nanoparticle (not to scale). 
3. Results and discussion  
3.1 Antibody microarray printing and quality 
One of the advantages of non-contact as compared to contact (pin based and other) printing 
methods is the inherently lower risk of damaging the substrate surface, which is especially 
relevant in the case of more fragile structures. This added property is expected to benefit the 
quality, functionality and reproducibility of the fabricated microarrays. 
 
 
 
Fig. 4. Droplet microarray obtained after printing of 40% (v/v) glycerol/water onto bare 
unmodified glass as observed by light microscopy. 
www.intechopen.com
 
Trends in Immunolabelled and Related Techniques 
 
318 
Unmodified, clean glass has a very hydrophilic nature leading to a tendency for droplets to 
spread out on the surface and, as a result, to touch each other and to coalesce. This can be 
overcome by using higher viscosity printing media, for example, 40% (v/v) glycerol in 
water. Printing of this solution onto bare glass delivers a nice regular droplet array as shown 
by the light microscopic image of Fig. 4. 
UltraStick slides, on the other hand, are useful substrates for printing of low viscosity 
solutions, even pure water, with no drop coalescence occurring and thereby yielding a 
proper array structure. The same is valid, to some lesser degree, for the SL HCX slides.  
Interestingly, IgG, BSA and other proteins (e.g., fosforylase B, cytochrome C, streptavidin 
and neutravidin) tend to adsorb spontaneously onto the UltraStick slide surface. This 
adsorption is rather strong stemming from the observation that ultrasonic treatment (for 
20 min) and long soaking (for up to 2 days) in detergent solution (5% Tween-20 in PBS) did 
not lead to a significant extent of protein desorption.  
 
 
  
Fig. 5. Fluorescence micrographs of antibody microarrays obtained after printing (in 
triplicate) of different antibody concentrations on UltraStick slides. Left panel: 
fluorescein-labelled Mouse IgG; Right panel: array obtained after printing with human IgG 
and consecutive incubation of the printed array with fluorescein-labelled goat anti-human 
IgG. Fluorescein-labelled HSA, BSA and dextran were used as references. 
The fluorescence images obtained with arrays of fluorescein-labelled mouse IgG are shown 
in Fig. 5, left panel. Spot fluorescence intensity increased with increasing printing 
concentration, in the range from 20 to 300 µg/mL. 
However, immobilised protein already appeared to be present after printing and incubation 
at much lower printing concentrations (down to 1 µg/mL). This was deduced from an 
amplified detection test in which mouse IgG arrays were incubated with fluorescein-labelled 
detecting antibody (anti-mouse IgG) (Fig. 5, right panel). 
The reproducibility of printing on the UltraStick slides, as judged by fluorescence 
microscopy on a large number of arrays, seemed to be low. A lot of variation was seen in 
brightness and brightness pattern when comparing spots. 
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3.2 Amplicon detection assay 
3.2.1 Introduction 
A series of experiments was performed with Bacillus cereus amplicons to evaluate the signal 
on three types of microscope slides: UltraStick slides, SL HCX slides and nitrocellulose-
coated FAST16 slides.  
On nitrocellulose FAST16 slides the detection of Listeria monocytogenes and Listeria 16S rRNA 
amplicons was optimised for critical parameters such as stirring speed, incubation volume 
and time, amount of carbon suspension, amount of antibody printed and amount of PCR 
product added. On the same slides incubations were performed to detect several antibiotic 
resistance genes from Salmonella spp. The specific amplicons were discriminated by using 
various tags and the antibodies to those tags were spotted in a distinguishing pattern. 
3.2.2 Choice of target substrate 
A comparison was made between the final yields obtained with UltraStick slides (APTES 
surface), XanTec slides (pre-activated hydrogel coating) and Whatman FAST16 slides 
(coated with nitrocellulose). Different amounts of tagged amplicons of B. cereus were mixed 
with various volumes of 0.2% (w/v) colloidal carbon nanoparticles-neutravidin conjugate in 
a total volume of 70 μL and incubated at room temperature for 7.5 min to several hours. 
Initial results indicated that approximately 0.5 to 2 μL of PCR material, 1 μL carbon 
conjugate and incubation for 15 min to 1 hour is sufficient to obtain significant results by 
flatbed scanning and image analysis (Fig. 6). Although these results with UltraStick seemed 
fine in first instance, they were not very reproducible and the response faded very soon after 
incubation.  
  
Fig. 6. Antibody microarray with serial dilutions of printed antibodies on UltraStick target. 
Left panel: influence of amount of amplicon added and antibody concentration, 1 µL carbon 
conjugate, 4 hours incubation time; Right panel influence of antibody concentration and 
incubation time, 1 µL of carbon conjugate and 1 µL of amplicon. 
The SL HCX hydrogel slides did not deliver much signal in the amplicon detection assay 
even when larger printing concentrations of IgG (up to 4000 µg/mL) were applied during 
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the preliminary step of array fabrication. Spots became increasingly visible in the 
concentration range of 400 up to 3000 µg/mL, but even then the response remained modest.  
The results with the activated hydrogel SL HCX slides were very disappointing, since it was 
expected that due to its larger loading capacity and presumed lower non-specific binding, 
the use of such a gel layer could be advantageous compared to a planar sensor surface. 
Unfortunately, it was not possible to assess the level of porosity of the gel layer and, 
therefore, it cannot be excluded that it may have limited accessibility for carbon 
nanoparticles ( 100-200 nm). This is supported by our report of a restricted accessibility of 
sensor hydrogel surfaces toward latex beads (Besselink et al. 2004) that have a size 
comparable to that of the carbon nanoparticles used in the present study.  
Results with Whatman FAST16 slides were promising (Fig. 3b). This was a little bit 
unexpected considering its behaviour during antibody printing. The hydrophilic coating on 
the FAST16 slides showed very fast absorption and migration of the liquid from spotted 
droplets always leading to an extensive overlap of fluid area between neighbouring spots. 
Nevertheless, in the end, well defined spots were obtained with the colloidal 
carbon/amplicon test. Apparently, adsorption of antibody (proteins) to the nitrocellulose 
substrate is an instantaneous process. FAST16 slides were used in all further experiments. 
3.2.3 Single - analyte detection using the antibody microarray 
Increasing the stirring speed from 100 to 500 min-1 revealed that the influence of stirring 
speed on the final signal is only marginal, at least for the speeds applied (Fig. 7). The stirring 
speed of 300 min-1 was used in all further experiments. It is shown here that the response is 
increasing with increasing antibody concentration up to a concentration of 333 µg/mL. 
 
Fig. 7. Influence of stirring speed on pixel grey level, shown for different antibody 
concentrations, 1 µL of carbon-neutravidin conjugate, 1 µL of DIG-tagged Listeria amplicons, 
25 µL total incubation volume and 30 min incubation time. 
A series of incubation times of 7.5 to 60 min revealed that 30 min was sufficient to 
statistically discriminate between different spots if 1 µL of amplicon was added (Fig. 8). As 
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measured with the Bioanalyzer this volume corresponded to 31.5 ng DNA in the Listeria 
monocytogenes amplicon solution and to 41 ng in the Listeria spp. amplicon solution.  
In another experiment the incubation buffer amount varied from 25, 50 to 75 µL, which 
revealed that 25 µL is enough for a good and reproducible response, although 75 µL is 
advised by the supplier and, indeed, more convenient. In addition, nitrocellulose pads were 
better wetted with 75 µL as compared to 25 µL total volume. 
  
  
Fig. 8. Influence of incubation time and amount of added amplicon Listeria monocytogenes 
with DIG as label and Listeria spp. with FL as label. Two concentrations of antibody were 
spotted with two different printing buffers. 
The amount of amplicon added varied from 0.5, 1 to 2 µL, where 1 µL was sufficient to give 
a good signal, corresponding to an amount of 20-300 fmol sample DNA with similar 
concentrations of DNA in both samples (31.5 vs. 41 ng DNA/µL for Listeria monocytogenes 
amplicon solution and the Listeria spp., respectively). Increasing the concentration of the 
printed antibody showed an optimum for 333 µg/mL for this combination of labelled 
amplicon and antibody. 
A summary of the influence of buffer volume, antibody concentration and incubation time is 
shown in Fig. 9 for digoxigenin and in Fig. 10 for fluorescein as a tag. In the case of the anti-
DIG antibody signal intensity increased upon printing more antibody molecules per spot up 
to a concentration of 333 µg/mL. For the influence of the anti-FL antibody concentration no 
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clear conclusions could be drawn. In addition, the total incubation volume was not of much 
influence, which was similar in the anti-DIG incubations. Whereas in the incubations with 
the anti-DIG antibody the signal intensity was higher in the 30 minutes as compared to the 
10 minutes incubation, no differences could be seen in the case of the anti-FL antibody.  
 
Fig. 9. Influence of the ǂ-DIG antibody concentration (37, 111, 333, or 1000 µg mL-1), 
incubation time (10 or 30 min) and volume (25, 50 or 75 µL from left to right) using 1 µL of 
the amplicon of L. monocytogenes labelled with biotin and DIG, 1 µL of carbon-neutravidin 
conjugate, a stirring speed of 300 min-1, and two incubation times: 10 min or 30 min. 
 
Fig. 10. Influence of the ǂ-FL antibody concentration (37, 111, 333, or 1000 µg mL-1); 
conditions as described under Figure 9 except for the amplicon: 1 µL of the amplicon of 
Listeria 16S RNA labelled with biotin and fluorescein. 
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Obviously, optimisation of a microarray immunoassay is dependent on the particular 
antibodies used and, hence, should be a compromise to enable acceptable sensitivity of all 
targets involved. 
In addition, only PBS was used as a printing buffer, since from the preceding and other (not 
shown) experiments it was concluded that the results in PBS and in 100 mM borate pH8.8 
were very similar. Since commercial antibodies are often shipped in or lyophilized from PBS 
it was decided to use this buffer in all further experiments. 
 
Fig. 11. Reproducibility of a FAST16 slide microarray with 1 µL of a L. monocytogenes 
amplicon using biotin and DIG as the tags, 14 arrays with 9 spots each of BSA-biotin, ǂ-DIG 
125 µg mL-1, ǂ-DIG 500 µg mL-1 and 1 µL of carbon conjugate. The total volume was 25 µL 
and samples were incubated for 30 min at a stirring speed of 300 min-1. 
The reproducibility of the assay using the above-mentioned optimized parameters was 
evaluated using 14 individual microarrays with nine spots each of BSA-biotin (500 µg mL-1), 
ǂ-DIG (125 µg mL-1) and ǂ-DIG (500 µg mL-1). Amplicons used were 1 µL of the DIG-
labelled L. monocytogenes type, 1 µL of the carbon-conjugate suspension in a total volume of 
25 µL. Incubation time was 30 min. Blanks were evaluated using empty spots. Results are 
shown in Fig. 11. An intra-assay standard error of less than 10% was achieved and an inter-
assay standard error of less than 20% was calculated. These results clearly show the 
reproducibility of the test.  
Optimisation of several parameters in the three-analyte approach was performed using the 
amplified products of S. typhimurium antibiotic resistance genes (Table 1). Serial dilutions of 
ǂ-TxR, ǂ-DIG or ǂ-DNP antibody (1000, 500, 250, 125, 62.5 or 31.25 µg mL-1) were printed. 
Judged from a fixed amount of carbon-neutravidin conjugate (1 µL) and serial dilutions of 
amplicon (0.125, 0.5, 1, or 2 µL), 1 µL of each of the amplicons proved to be optimal for a 
good response (Fig. 12), although 0.125 µL could be positively scored in all cases as well. 
Based on a fixed amount of amplicon (i.e., 1 µL) and serial dilutions of carbon-neutravidin 
conjugate (0.5, 1, 2, 4 µL) the optimal amount of the carbon-neutravidin conjugate 
suspension was 1-2 µL at antibody concentrations of 125-250 µg mL-1 (Fig 12). 
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Fig. 12. Contour plots of the influence of addition of amount of amplicon and carbon-
neutravidin conjugate. Initial results of individual additions of the tagged amplicons of 
some of the Salmonella antibiotic resistance genes. Shown here are the products tagged with 
texas red (left upper panel), dinitrophenol (right upper panel) and digoxigenin (lower 
panel).  
3.2.4 Three - analyte detection using the antibody microarray 
The response of the addition of a mixture of the individually amplified and labelled 
antibiotic resistance genes is shown in Fig. 13. No quantification of the DNA content of the 
amplicons was made, and 0.5 µL of each amplicon was added to each well. Serial dilutions 
of antibodies printed showed a concentration-dependent response for every amplicon-
antibody pair. The total volume was 25 µL and the samples were incubated for 30 min, 
however, in this case 2 µL of the carbon conjugate suspension was used. 
Signals with the anti-DNP antibodies were twice as high as those with the other anti-tag 
antibodies and the optimal antibody concentration appeared to be 125 to 250 µg/mL. 
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Fig. 13. Response of the multi-analyte format when serial dilutions of the three antibodies 
were spotted. Incubation was done with addition of 0.5 µL of each of the Salmonella 
amplicons of the antibiotic resistance genes, 2 µL of carbon conjugate suspension in 25 µL of 
incubation volume. Incubation time was 30 min. 
 
Tagged amplicons added Pixel Grey Volume 
Dig DNP TxR ǂ-Dig ǂ-DNP ǂ-TxR 
- - - 0 0 0 
+ + + 1.3x105 2.5x105 1.1x105 
+ - - 1.6x105 0 0 
- + - 0 3.4x105 0 
- - + 0 0 1.5x105 
+ + - 1.7x105 3.0x105 0 
+ - + 1.6x105 0 1.5x105 
- + + 0 3.2x105 1.1x105 
Table 2. Specificity in the three-analyte test (PGV average of 2 tests). 
To study whether the simultaneous presence of various targets could be detected in the 
microarray an experiment was done in which the amplicons, each having a specific DNP, 
DIG, or TxR tag, were incubated in different combinations. Fixed amounts of anti-tag 
antibodies were used (125 µg/mL for each of the antibodies). The results are presented in 
Table 2. In all cases the presence of a particular amplicon resulted in a high-intensity spot 
with PGV > 1x105. In the absence of a particular amplicon no PGV was detected. Hence, all 
scores correctly indicated the composition of the various samples.  
The most optimal parameters in this format are summarised in Table 3. With minimal 
volume of 1 µL of amplicon (containing 20 to 30 fmol DNA after amplification), a printing 
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volume of 1 nL containing 125-250 pg of antibody (absolute amount) and low-cost resources 
it is possible to discriminate between three antibiotic resistance genes from Salmonella spp. 
 
Stirring speed 300 min-1 
Incubation time 30 min 
Volume 25 to 50 µL 
Antibody spotted 125-250 µg mL-1 
Carbon nanoparticles 2 µL 
PCR amplicon (20 to 30 fmol; 20 to 300 nmol L-1) 1 µL 
Table 3. Most optimal parameters in the 3-analyte format. 
3.3 Costs 
Assuming the end-user obtains printed antibody microarrays several costs have to be taken 
into account. Kits for DNA extraction should be purchased, although recent advances allow 
for direct PCR on samples if very robust polymerases are being used. Furthermore, some 
hard- and software is obligatory. These consist of a thermocycler, a personal computer with 
flatbed scanner or CCD camera and image analysis software. The price of the chemicals 
(conjugate, PCR reagents) is less than 1 euro per slide. However, one should realize that 
applications as outlined above, when applied in resource-poor settings, at least need the 
availability of electricity. 
4. Conclusions and future research 
Carbon nanoparticles with adsorbed neutravidin are suitable as label in nitrocellulose-based 
antibody microarrays. The versatility has been shown using different types of 
microorganisms. The format is generic; the only discriminating factor is the sequence of the 
primers used in the amplification step and the use of the discriminating tag/antibody 
combination. Although much more space is available on the nitrocellulose pads (5x5 mm) 
we used 4x6 arrays with spots of about 200 µm in diameter to study the applicability of the 
carbon nanoparticles. Unfortunately, there is a paucity in tags and/or their corresponding 
antibodies that can be used to discriminate between all kinds of food pathogens. Increasing 
the availability of label/antibody combinations will be a significant improvement in the 
multi-analyte character of the microarray test procedure as described here. 
The best surface for the microarrays as developed in this study is the FAST16 slide with 16 
nitrocellulose membranes. We did not have to block the membranes in advance, as is 
generally done (Jonkheijm et al. 2008). Nevertheless, this one-step procedure resulted in a 
complete absence of background signal (Fig. 11).  
The sensitivity of the proposed microarray procedure with carbon nanoparticles can be 
improved when a fusion product of neutravidin and enzyme is adsorbed onto the 
nanoparticles. To this end, neutravidin - alkaline phosphatase and - horseradish peroxidase 
products are commercially available. Carbon nanoparticles can be labelled with these 
protein fusion products and specific interaction of these conjugates with biotin-labelled 
targets results in the presence of a large number of enzyme molecules at the spot. A short, 
additional incubation step with a precipitating substrate (10 min) substantially increases the 
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signal due to the formation of a precipitable dye on the spot. Preliminary experiments in our 
laboratory indicate that the sensitivity (PGV) can be increased by a factor 5 to 10. 
Nowadays, various nanoparticles are used in diagnostics, i.e. quantum dots, dye-doped 
silica, noble metals, and magnetic particles as reviewed (Gomez-Hens et al. 2008). Lönnberg 
and Carlsson were the first to combine carbon nanoparticles with flatbed scanning 
(Lonnberg & Carlsson 2001). Some other authors also mentioned the use of flatbed scanning 
using gold nanoparticles (Han et al. 2003; Sun et al. 2007; Taton et al. 2000) or enzyme 
(Petersen et al. 2007). Inexpensive flatbed scanners and CCD-based detectors open new 
opportunities to develop microarray applications, even for low-facility laboratories and 
under field conditions (Rasooly & Herold 2008). Even a visual read-out of the signal is 
possible when coloured nanoparticles are being used as is valid for the carbon nanoparticles 
in this study. On the other hand, battery-powered hand-held microarray readers for 
evaluation of the signal are readily available as well. Since shaking can even be omitted 
(results not shown) the method can easily be made available to resource-poor settings. 
Antibody microarrays are especially applicable when intermediate numbers of samples 
have to be assayed, application at point of care/need is required, when costs play an 
important role and highly trained personnel is not available. The presented procedure with 
signal generation by carbon nanoparticles meets these characteristics. 
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